Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Feb 28, 2014
Insider Transaction Report
Form 4
Logerfo Michael
Chief Legal Officer
Transactions
- Sale
Common Stock
2014-02-27$21.43/sh−2,021$43,310→ 33,011 total
Holdings
- 1,000(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.36 to $21.54, inclusive.
- [F2]Shares held by a member of Mr. Logerfo's immediate family sharing the same household. Mr. Logerfo disclaims beneficial ownership of such shares.